779344-30-8

Basic information

• Product Name: 3-BROMO-6-METHYLPICOLINIC ACID
• Synonyms: 3-BROMO-6-METHYLPICOLINIC ACID;3-BROMO-6-METHYLPYRIDINE-2-CARBOXYLIC ACID;2-Pyridinecarboxylicacid,3-bromo-6-methyl-(9CI);3-Bromo-6-methyl-2-pyridinecarboxylic acid
• CAS NO: 779344-30-8
• Molecular Formula: C7H6BrNO2
• Molecular Weight: 216.03
• Product Categories: METHYL
• Mol File: 779344-30-8.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 314.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.692±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 2.36±0.10(Predicted)
• CAS DataBase Reference: 3-BROMO-6-METHYLPICOLINIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-6-METHYLPICOLINIC ACID(779344-30-8)
• EPA Substance Registry System: 3-BROMO-6-METHYLPICOLINIC ACID(779344-30-8)

Safety Data

• Hazardous Substances Data: 779344-30-8(Hazardous Substances Data)

Usage

General Description

3-Bromo-6-methylpicolinic acid is an organic chemical compound with the molecular formula C7H6BrNO2. It is a derivative of picolinic acid, and its structure consists of a pyridine ring with a bromine atom and a methyl group attached to it. 3-BROMO-6-METHYLPICOLINIC ACID has various applications, including as a building block in the synthesis of pharmaceuticals and agrochemicals. It is also used in academic research as a starting material for the preparation of complex organic molecules. Additionally, 3-bromo-6-methylpicolinic acid has potential biological activities and is studied for its antibacterial and antifungal properties.

Upstream product

• 31181-64-3 5-bromo-2-methyl-pyridine-N-oxide 
• 3430-13-5 5-bromo-2-methylpyridine 
• 717843-48-6 3-bromo-6-methylpyridine-2-carbonitrile 

Downstream Products

• 1060810-14-1 3-bromo-6-methyl-2-pyridinecarboxaldehyde 

Relevant articles and documents

FUSED HETEROCYCLIC DERIVATIVES, THEIR PREPARATION METHODS THEREOF AND MEDICAL USES THEREOF

The present invention relates to fused heterocyclic derivatives, processes for their preparation and their use in medicine. Specifically, the present invention relates to a novel derivative represented by the formula (I′), or its pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the derivative or its pharmaceutically acceptable salt thereof, and the method for preparing the derivative and its pharmaceutically acceptable salt thereof. The present invention also relates to the use of the derivative and its pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing the derivative and its pharmaceutically acceptable salt thereof in the preparation of medicines, in particularly as IDO inhibitor medicines, for treating and/or preventing cancers. Wherein each substituent of the formula (I′) is the same as defined in the specification.

SUBSTITUTED 7-AZABICYCLES AND THEIR USE AS OREXIN RECEPTOR MODULATORS

The present invention is directed to compounds of Formula I: wherein ring A is phenyl, naphihalenyl, pyridyl, quinolinyl, isoquinolinyl, imidazopyridyl, furanyi, tlisazolyl, isoxazolvl, pyrazolyl, imidazothiazolyi, benzimidazolyl, or indazolyi; R1 is H, alky], aikoxy, hydroxyalkylene, OH, halo, phenyl, triazolyl, oxazolyl, isoxazofyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazmyl, piperazinyl, pyrazolyl, oxadiazolvl, pyrrolidinyl, thiophenyi, morpholinyl, or dialkyiamino; R2 is H, alkyl, aikoxy, hydroxyalkylene, or halo; Z is NH, N-alkyl, or O; R5 is pyridyl, pyrimidinyl, pyrazinyl, pyridazmyl, qumazolinyi, quinoxalinyl, pyrazolyl, benzoxazolyl, imidazopyrazinyl, triazolopyrazinyl, optionally substituted with a one or two substituents independently selected from the group consisting of alkyl, aikoxy, or halo; and n is 0 or 1, Methods of making the compounds of Formula 1 are also described. The invention also relates to pharmaceutical compositions comprising compounds of Formula I. Methods of using the compounds of the invention are also within the scope of the invention.